Though drug recalls are relatively uncommon in the U.S., reduced inspections increase the likelihood of manufacturing errors that slip through the cracks.
The FDA’s Weak Drug Manufacturing Oversight Is A Potentially Deadly Problem
by | Jun 25, 2021 | Uncategorized | 0 comments
Recent Comments